Toxic epidermal necrolysis associated with rifaximin-Reference-Cited by-同舟云学术

Toxic epidermal necrolysis associated with rifaximin

Published:2013-05-15 Issue:10 Volume:70 Page:874-876
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Patel Aneesh S.¹,Supan Elisa M.²,Ali Shereef N.³

Affiliation:

1. In Clinical Development, Allergan, Inc., Irvine, CA

2. Methodist Willowbrook Hospital, Houston, TX; at the time of writing, she was Clinical Pharmacy Specialist, Kennedy Health System, Washington Township Division, Turnersville, NJ

3. Kennedy Health System, Cherry Hill Division, Cherry Hill, NJ

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/70/10/874/28363902/ajhp0874.pdf

Reference12 articles.

1. Rifaximin treatment in hepatic encephalopathy;Bass;N Engl J Med,2010

2. Treatment of hepatic encephalopathy;Riordan;N Engl J Med,1997

3. Food and Drug Administration. FDA approves new use of Xifaxan for patients with liver disease. www.fda.gov/newsevents/newsroom/pressannouncements/ucm206104.htm (accessed 2013 Feb 8).

4. Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy;Bucci;Curr Med Res Opin,1993

5. Rifaximin: a novel antimicrobial for enteric infections;Huang;J Infect,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of the Dipole Potential of Model Lipid Membranes with Phytochemicals: Molecular Mechanisms, Structure–Activity Relationships, and Implications in Reconstituted Ion Channels;Membranes;2023-04-21

2. Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis;Hepatology International;2021-01-01

3. Non-Immediate Hypersensitivity Reaction to Rifaximin Confirmed With a Drug Challenge Test;Journal of Investigational Allergology and Clinical Immunology;2020-12-21

4. Predicting Adverse Drug Effects from Literature- and Database-Mined Assertions;Drug Safety;2018-06-06

5. Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study;Journal of Digestive Diseases;2015-11